ThermoGenesis Holdings Inc (FRA:THR)
€ 1.62 0 (0%) Market Cap: 2.52 Mil Enterprise Value: 6.56 Mil PE Ratio: 0 PB Ratio: 2.60 GF Score: 30/100

Thermogenesis Holdings Inc Celebrates Its 35th Anniversary As A Cell And Gene Therapy-Focused Company Transcript

Feb 17, 2021 / NTS GMT
Release Date Price: €139.5 (-4.91%)
Christine Corrado
Proactive Investors - Moderator

Hello, and thanks so much for watching Proactive New York. With me right now is Phil Coelho, Chief Technology Officer and Co-Founder at ThermoGenesis. Phil, it's great to meet you. How are you?

Phil Coelho
ThermoGenesis Holdings, Inc. - Co-Founder & Chief Technology Officer

I'm fine. Thank you.

Questions & Answers

Christine Corrado
Proactive Investors - Moderator

Phil, I understand the group is celebrating their 35th anniversary today, so congratulations on that. Can you give me a brief intro into the company and history?

Phil Coelho
ThermoGenesis Holdings, Inc. - Co-Founder & Chief Technology Officer

Yeah, it was originally a pure engineering design company. And in fact, the first couple of product lines that had developed were actually sold to other larger companies who had bigger distribution pipelines, et cetera. The third product line was -- put us in the stem cell business. And what stem cells were

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot